Royal Bank of Canada
AVEO

Royal Bank of Canada’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Royal Bank of Canada’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-770
Closed -$6K – 7391
2019
Q1 		$6K Buy
+770
New +$7.95K ﹤0.01% 6235

Royal Bank of Canada's AVEO Position: Q1 2023 in Review

Royal Bank of Canada sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 80 shares — an estimated $1K sold.

Royal Bank of Canada first reported a position in AVEO in Q2 2013 and held it in 23 quarters. The position peaked at $88K in Q2 2013. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

  • Royal Bank of Canada reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Royal Bank of Canada sold 80 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $1K.
  • Royal Bank of Canada first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 23 quarters.
  • Royal Bank of Canada's AVEO Pharmaceuticals, Inc. position peaked at $88K in Q2 2013.
  • 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Royal Bank of Canada's 13F filing for Q1 2023, filed 15 May 2023.